Adalta Capital Management LLC Has $2.36 Million Stock Position in Danaher Co. (NYSE:DHR)

Adalta Capital Management LLC increased its holdings in shares of Danaher Co. (NYSE:DHR - Free Report) by 52.3% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 8,467 shares of the conglomerate's stock after acquiring an additional 2,907 shares during the period. Danaher comprises approximately 1.2% of Adalta Capital Management LLC's holdings, making the stock its 19th largest holding. Adalta Capital Management LLC's holdings in Danaher were worth $2,356,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. Benjamin Edwards Inc. raised its holdings in Danaher by 1.8% in the 2nd quarter. Benjamin Edwards Inc. now owns 2,153 shares of the conglomerate's stock valued at $538,000 after buying an additional 38 shares during the period. Wedge Capital Management L L P NC lifted its stake in Danaher by 3.2% during the third quarter. Wedge Capital Management L L P NC now owns 1,231 shares of the conglomerate's stock worth $342,000 after purchasing an additional 38 shares in the last quarter. Patrick M Sweeney & Associates Inc. boosted its position in shares of Danaher by 3.4% during the second quarter. Patrick M Sweeney & Associates Inc. now owns 1,230 shares of the conglomerate's stock worth $307,000 after buying an additional 40 shares during the period. Trust Co of Kansas grew its stake in shares of Danaher by 4.1% in the second quarter. Trust Co of Kansas now owns 1,022 shares of the conglomerate's stock valued at $255,000 after buying an additional 40 shares in the last quarter. Finally, Abacus Planning Group Inc. lifted its stake in Danaher by 0.7% during the 2nd quarter. Abacus Planning Group Inc. now owns 5,439 shares of the conglomerate's stock worth $1,359,000 after acquiring an additional 40 shares in the last quarter. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of research firms recently issued reports on DHR. KeyCorp lifted their target price on Danaher from $290.00 to $310.00 and gave the company an "overweight" rating in a report on Wednesday, October 23rd. Stephens reissued an "overweight" rating and set a $315.00 price objective on shares of Danaher in a research report on Wednesday, October 23rd. StockNews.com downgraded shares of Danaher from a "buy" rating to a "hold" rating in a research note on Thursday. UBS Group dropped their price objective on shares of Danaher from $309.00 to $305.00 and set a "buy" rating on the stock in a research report on Wednesday, October 23rd. Finally, Royal Bank of Canada decreased their price objective on shares of Danaher from $333.00 to $311.00 and set an "outperform" rating for the company in a research report on Wednesday, October 23rd. Six analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the stock. Based on data from MarketBeat.com, Danaher presently has an average rating of "Moderate Buy" and a consensus price target of $287.16.

Danaher Stock Performance

Shares of NYSE:DHR traded up $5.78 on Monday, hitting $235.91. The company had a trading volume of 2,625,253 shares, compared to its average volume of 2,779,061. The stock has a 50 day moving average price of $250.76 and a 200 day moving average price of $258.32. The company has a current ratio of 1.37, a quick ratio of 1.01 and a debt-to-equity ratio of 0.32. The stock has a market cap of $170.39 billion, a price-to-earnings ratio of 43.92, a P/E/G ratio of 4.23 and a beta of 0.83. Danaher Co. has a 1-year low of $217.96 and a 1-year high of $281.70.

Danaher (NYSE:DHR - Get Free Report) last released its quarterly earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 EPS for the quarter, topping analysts' consensus estimates of $1.57 by $0.14. Danaher had a net margin of 16.39% and a return on equity of 10.62%. The business had revenue of $5.80 billion for the quarter, compared to analyst estimates of $5.59 billion. During the same period last year, the firm earned $2.02 earnings per share. Danaher's revenue for the quarter was up 3.1% compared to the same quarter last year. Analysts expect that Danaher Co. will post 7.5 EPS for the current year.

Danaher Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, October 25th. Stockholders of record on Friday, September 27th were paid a dividend of $0.27 per share. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.46%. The ex-dividend date was Friday, September 27th. Danaher's payout ratio is 20.61%.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.